Merlin in organ size control and tumorigenesis: Hippo versus EGFR?

Por Yi, Chunling, Kissil, Joseph L.
Publicado em 2010

WT1: a weak spot in KRAS-induced transformation

Por Licciulli, Silvia, Kissil, Joseph L.
Publicado em 2010

Notch signaling in pancreatic cancer: Oncogene or tumor suppressor?

Por Avila, Jacqueline L., Kissil, Joseph L.
Publicado em 2013

The angiomotins – from discovery to function

Por Moleirinho, Susana, Guerrant, William, Kissil, Joseph L.
Publicado em 2014

Organization of Myelinated Axons by Caspr and Caspr2 Requires the Cytoskeletal Adapter Protein 4.1B

Por Horresh, Ido, Bar, Vered, Kissil, Joseph L., Peles, Elior
Publicado em 2010

Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancer

Por Yi, Chunling, Maksimoska, Jasna, Marmorstein, Ronen, Kissil, Joseph L
Publicado em 2010

Notch1 Is Not Required for Acinar-to-Ductal Metaplasia in a Model of Kras-Induced Pancreatic Ductal Adenocarcinoma

Por Avila, Jacqueline L., Troutman, Scott, Durham, Amy, Kissil, Joseph L.
Publicado em 2012

Death-Associated Protein Kinase-Related Protein 1, a Novel Serine/Threonine Kinase Involved in Apoptosis

Por Inbal, Boaz, Shani, Gidi, Cohen, Ofer, Kissil, Joseph L., Kimchi, Adi
Publicado em 2000

Targeting fibroblast activation protein inhibits tumor stromagenesis and growth in mice

Por Santos, Angélica M., Jung, Jason, Aziz, Nazneen, Kissil, Joseph L., Puré, Ellen
Publicado em 2009

Non-Small Cell Lung Carcinoma Cell Motility, Rac Activation and Metastatic Dissemination Are Mediated by Protein Kinase C Epsilon

Por Caino, M. Cecilia, Lopez-Haber, Cynthia, Kissil, Joseph L., Kazanietz, Marcelo G.
Publicado em 2012

Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators

Por Stedman, William, Kang, Hyojeung, Lin, Shu, Kissil, Joseph L, Bartolomei, Marisa S, Lieberman, Paul M
Publicado em 2008

Validation of the p21-activated kinases as targets for inhibition in neurofibromatosis type 2

Por Yi, Chunling, Wilker, Erik W., Yaffe, Michael B., Stemmer-Rachamimov, Anat, Kissil, Joseph L.
Publicado em 2008

Regulation of localization and function of the transcriptional co-activator YAP by angiomotin

Por Moleirinho, Susana, Hoxha, Sany, Mandati, Vinay, Curtale, Graziella, Troutman, Scott, Ehmer, Ursula, Kissil, Joseph L
Publicado no eLife (2017)

Loss of the Putative Tumor Suppressor Band 4.1B/Dal1 Gene Is Dispensable for Normal Development and Does Not Predispose to Cancer

Por Yi, Chunling, McCarty, Joseph H., Troutman, Scott A., Eckman, Matthew S., Bronson, Roderick T., Kissil, Joseph L.
Publicado em 2005

YAP mediates tumorigenesis in neurofibromatosis type 2 by promoting cell survival and proliferation through a COX-2-EGFR signaling axis

Por Guerrant, William, Kota, Smitha, Troutman, Scott, Mandati, Vinay, Fallahi, Mohammad, Stemmer-Rachamimov, Anat, Kissil, Joseph L.
Publicado no Cancer Res (2016)

Crizotinib inhibits NF2-associated schwannoma through inhibition of focal adhesion kinase 1

Por Troutman, Scott, Moleirinho, Susana, Kota, Smitha, Nettles, Kendall, Fallahi, Mohammad, Johnson, Gary L., Kissil, Joseph L.
Publicado no Oncotarget (2016)

Dap-Kinase Participates in TNF-α–And FAS-Induced Apoptosis and Its Function Requires the Death Domain

Por Cohen, Ofer, Inbal, Boaz, Kissil, Joseph L., Raveh, Tal, Berissi, Hanna, Spivak-Kroizaman, Taly, Feinstein, Elena, Kimchi, Adi
Publicado em 1999

REGULATION OF LUNG CANCER METASTASIS BY Klf4-Numb-like SIGNALING

Por Vaira, Valentina, Faversani, Alice, Martin, Nina M., Garlick, David S., Ferrero, Stefano, Nosotti, Mario, Kissil, Joseph L., Bosari, Silvano, Altieri, Dario C.
Publicado em 2013

Protein 4.1B suppresses prostate cancer progression and metastasis

Por Wong, Sunny Y., Haack, Herbert, Kissil, Joseph L., Barry, Marc, Bronson, Roderick T., Shen, Steven S., Whittaker, Charles A., Crowley, Denise, Hynes, Richard O.
Publicado em 2007

FRAX597, a Small Molecule Inhibitor of the p21-activated Kinases, Inhibits Tumorigenesis of Neurofibromatosis Type 2 (NF2)-associated Schwannomas

Por Licciulli, Silvia, Maksimoska, Jasna, Zhou, Chun, Troutman, Scott, Kota, Smitha, Liu, Qin, Duron, Sergio, Campbell, David, Chernoff, Jonathan, Field, Jeffrey, Marmorstein, Ronen, Kissil, Joseph L.
Publicado em 2013